Your faith in NAL is about to be realised. Latest eye care announcemnet gives it control of the patent position for the Epi-Lasik market internationally. NAL now needs to enter into an exclusive licence agreement with one of the major players in this market and wait for the royalties and consumable revenues to roll in.
In 2001 there were about 1.8 million laser correction procedures performed. Don't know current stats but they would be well up on this as the procedure has become safer and easier.Total US optical industry (including retail eye ware sales, surgical fees, exam fees etc.) in Nth USA was $30.2 billion in 1998.
Big market, NAL has patent position locked in and should now be negotiating for an exclusive licence arrangement. Should be a short wait for royalty incomes to start flowing.
NAL Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
